V

Veru
D

VERU

0.61660
USD
0.01
(1.00%)
مفتوح الان
حجم التداول
5,885
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
90,383,645
أصول ذات صلة
A
ALT
0.09500
(1.37%)
7.01000 USD
A
AQST
0.09000
(2.63%)
3.51000 USD
D
DRRX
0.00920
(1.44%)
0.64920 USD
S
SND
-0.04000
(-1.87%)
2.10000 USD
T
TNXP
2.800
(8.80%)
34.610 USD
المزيد
الأخبار المقالات

العنوان: Veru

القطاع: Healthcare
الصناعة: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.